Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient

被引：63
作者：
Thiolas, A
Bollet, C
La Scola, B
Raoult, D
Pagès, JM
机构：
[1] Univ Mediterranee, Fac Med, IFR48, EA2197, F-13385 Marseille, France
[2] Univ Mediterranee, Enveloppe Bacterienne Permeabil & Antibiot, EA2197, F-13385 Marseille, France
[3] Univ Mediterranee, Unite Rickettsies, CNRS, UMR6020, F-13385 Marseille, France
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 04期
关键词：
D O I：
10.1128/AAC.49.4.1354-1358.2005
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Enterobacter aerogenes is an agent of hospital-acquired infection that exhibits a remarkable resistance to beta-lactam antibiotics during therapy. Five successive isolates of E. aerogenes infecting a patient and exhibiting a multiresistance phenotype to beta-lactam antibiotics and fluoroquinollones were investigated. Among these clinical strains, four presented resistant phenotypes during successive imipenem and colistin treatments. The involved resistance mechanisms exhibited by the successive isolates were associated with alterations of the outer membrane that caused a porin decrease and lipopolysaccharide modifications.
引用
收藏
页码：1354 / 1358
页数：5
相关论文
共 35 条
[21]   The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting [J].
Ibrahim, EH ;
Sherman, G ;
Ward, S ;
Fraser, VJ ;
Kollef, MH .
CHEST, 2000, 118 (01) :146-155
[22]   Colistin for Klebsiella pneumoniae-associated sepsis [J].
Karabinis, A ;
Paramythiotou, E ;
Mylona-Petropoulou, D ;
Kalogeromitros, A ;
Katsarelis, N ;
Kontopidou, F ;
Poularas, I ;
Malamou-Lada, H .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (01) :E7-E9
[23]   Molecular epidemiology of Enterobacteriaceae isolates producing extended-spectrum β-lactamases in a French hospital [J].
Lavigne, JP ;
Bouziges, N ;
Chanal, C ;
Mahamat, A ;
Michaux-Charachon, S ;
Sotto, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (08) :3805-3808
[24]   Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa [J].
Linden, PK ;
Kusne, S ;
Coley, K ;
Fontes, P ;
Kramer, DJ ;
Paterson, D .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (11) :E154-E160
[25]   Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa:: Novel agents for combination therapy [J].
Lomovskaya, O ;
Warren, MS ;
Lee, A ;
Galazzo, J ;
Fronko, R ;
Lee, M ;
Blais, J ;
Cho, D ;
Chamberland, S ;
Renau, T ;
Leger, R ;
Hecker, S ;
Watkins, W ;
Hoshino, K ;
Ishida, H ;
Lee, VJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :105-116
[26]   Porin alteration and active efflux:: two in vivo drug resistance strategies used by Enterobacter aerogenes [J].
Mallea, M ;
Chevalier, J ;
Bornet, C ;
Eyraud, A ;
Davin-Regli, A ;
Bollet, C ;
Pagès, JM .
MICROBIOLOGY-UK, 1998, 144 :3003-3009
[27]   Inhibitors of antibiotic efflux pump in resistant Enterobacter aerogenes strains [J].
Malléa, M ;
Chevalier, J ;
Eyraud, A ;
Pagès, JM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 293 (05) :1370-1373
[28]   Coexistence of SHV-4-and TEM-24-producing Enterobacter aerogenes strains before a large outbreak of TEM-24-producing strains in a French hospital [J].
Mammeri, H ;
Laurans, G ;
Eveillard, M ;
Castelain, S ;
Eb, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (06) :2184-2190
[29]   Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients [J].
Markou, N ;
Apostolakos, H ;
Koumoudiou, C ;
Athanasiou, M ;
Koutsoukou, A ;
Alamanos, I ;
Gregorakos, L .
CRITICAL CARE, 2003, 7 (05) :R78-R83
[30]   Overlaps and parallels in the regulation of intrinsic multiple-antibiotic resistance in Escherichia coli [J].
Miller, PF ;
Sulavik, MC .
MOLECULAR MICROBIOLOGY, 1996, 21 (03) :441-448
1234